Diabetes News

The FDA is warning adults with diabetes to avoid using counterfeit semaglutide that may be circulating in the U.S. drug supply chain, according to a press release.

A group of adults with type 2 diabetes who used only telemedicine for endocrinology care did not have improvements in HbA1c over 2 years of follow-up, according to findings published in JAMA Network Open.

Women who quit smoking and were treated with the GLP-1 receptor agonist dulaglutide were less likely to experience substantial weight gain compared with those who received placebo, according to researchers.

Disordered eating behaviors were reported by 42.5% of adolescents with type 1 diabetes who currently use or previously used an insulin pump, according to findings published in Diabetes Technology & Therapeutics.

SAN DIEGO — Patients with diabetes mellitus who undergo total hip arthroplasty demonstrate an increased risk for health care use, including increased length of stay, and acute renal failure, according to a speaker at ACR Convergence 2023.

PHILADELPHIA — In the EMPA-ICD trial, patients with type 2 diabetes and an implantable cardioverter defibrillator had fewer ventricular arrhythmias at 24 weeks when assigned empagliflozin compared with placebo.

The development of incretin-based molecules has led to therapies that can induce greater reductions in HbA1c and body weight for people with type 2 diabetes and obesity than other classes of medication, according to a speaker

Almost 40% of patients with type 2 diabetes stopped taking their second-line medication within 1 year, putting them at risk for future hospitalization related to diabetes, according to researchers.

Composite CVD risk factor control for U.S. adults with type 2 diabetes remains poor, but clinicians can use newer risk scores to better assess patients and prevent CV events with targeted therapies, according to a speaker.

Medications that target bile acid-triggered pathways and combination therapies could be the key for treating nonalcoholic steatohepatitis for young people with obesity and type 2 diabetes, according to a speaker.